electroCore, Inc. (ECOR) vs Rallybio Corporation (RLYB)
A side-by-side comparison of electroCore, Inc. and Rallybio Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ECOR
electroCore, Inc.
$9.97HealthcareDelayed quote: Oct 6, 2026, 2:34 PM EDT
RLYB
Rallybio Corporation
$17.00HealthcareDelayed quote: Oct 6, 2026, 2:28 PM EDT
Total return — ECOR vs RLYB
growth of $100 · dividends reinvested · last 5yECOR -33.8% (-7.9%/yr)RLYB -85.0% (-31.6%/yr)ECOR compounded faster over this window
ECOR RLYB
ECOR vs RLYB: by the numbers
- •RLYB is the larger company ($90M vs $90M market cap).
- •RLYB is profitable (7051.24% net margin) while ECOR runs a net loss (-39.96%).
Metrics side by side
Valuation
| Metric | ECOR | RLYB |
|---|---|---|
| P/E ratio | N/A | 2.18 |
| P/S ratio | 2.43 | 139.66 |
| P/B ratio | N/A | 0.95 |
| FCF yield | N/A | 29.20% |
Profitability
| Metric | ECOR | RLYB |
|---|---|---|
| Gross margin | 87.06% | 89.28% |
| Operating margin | -37.64% | -3270.86% |
| Net margin | -39.96% | 7051.24% |
| ROE | N/A | 48.20% |
| ROIC | -217.73% | -24.40% |
Growth (annualized)
| Metric | ECOR | RLYB |
|---|---|---|
| Revenue CAGR (5Y) | 52.51% | N/A |
| Total return CAGR (5Y) | -8.10% | -35.80% |
Frequently asked
- Is ECOR or RLYB more profitable?
- RLYB runs the higher net margin — ECOR at -39.96% versus RLYB at 7051.24%.
- How have ECOR and RLYB total returns compared?
- Over the past 5 years, ECOR delivered -8.10% and RLYB delivered -35.80% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Rallybio P/E ratioelectroCore ROERallybio ROEelectroCore operating marginRallybio operating marginelectroCore revenue growthRallybio revenue growthelectroCore free cash flowRallybio free cash flow
electroCore & Rallybio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.